SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-016298
Filing Date
2019-03-20
Accepted
2019-03-20 13:47:43
Documents
8
Period of Report
2019-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6865_18k.htm 8-K 31464
2 EX-5.1 a19-6865_1ex5d1.htm EX-5.1 13403
3 EX-10.1 a19-6865_1ex10d1.htm EX-10.1 186452
4 EX-10.2 a19-6865_1ex10d2.htm EX-10.2 89915
5 EX-10.3 a19-6865_1ex10d3.htm EX-10.3 125342
6 GRAPHIC g68651ku03i001.jpg GRAPHIC 7646
7 GRAPHIC g68651ku01i001.jpg GRAPHIC 4163
8 GRAPHIC g68651kii001.gif GRAPHIC 1275
  Complete submission text file 0001104659-19-016298.txt   466533
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 19694324
SIC: 2836 Biological Products, (No Diagnostic Substances)